flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Preventing chronic disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global (KDIGO) Controversies Conference FLOW trial Ozempic® (semaglutide injection)

James Grant of Michigan BCBS summarized the frustration: "We were wasting millions of dollars, and people did not even see true benefit." From an actuarial perspective, the math was devastating

Both MK-801 and GLP-1 have been linked to improvements in glucose homeostasis in mice 20,21

Some chronic or severe injuries require extended protocols beyond typical 12-week durations

The largest increases in T2D diagnosis were observed in Class 3 obesity, while sleep apnea diagnosis rates saw the largest proportional growth in Class 1 obesity

Because tirzepatide delays gastric emptying, it could affect the absorption of oral medications taken concurrently, including birth control pills

What Makes a GLP-1-Friendly Breakfast